Our comprehensive service ensures you receive the medication, lab work, and unlimited support you need to succeed
A drug that works as an agonist activates the same cell receptors as the body's natural hormones
A 2025 meta-analysis published in Endocrinology, Diabetes & Metabolism, pooling data from four studies with nearly 29,000 patients, confirmed a consistent advantage for tirzepatide, with an average additional weight reduction of 4.84 kg compared to semaglutide
In the analysis that most closely reflects real-world clinical practice, participants taking oral semaglutide lost an average of 13.6% of their starting body weight, compared with just 2.4% in those receiving placebo
Ozempic 0.5 mg solution for injection in pre-filled pen Summary of Product Characteristics
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums